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FEATURE
NO LASIX RACING: 
Good Idea or Failed Experiment?
A closer look at the concept and what it means for the safety of horses and riders
By Clara Fenger, DVM, PhD, DACVIM; Thomas Tobin, DVM, PhD, DACT; Peter Ecabert, JD
syncopatedphoto - stock.adobe.com
The watch showed :51 3/5. Not a stopwatch breaker, but our trainer liked the 
way the big bay horse did it. He galloped strong to the pole and quickened with 
each quarter, reaching a little further with each stride, and the gallop out was 
strong. Our trainer had only a few years of training under his belt, but he had a 
solid foundation of experience growing up in a racetrack family. He had owned 
only one other horse and was ready to jump back in. He’d had his eye on the bay 
for a while and was ready to pull the trigger. The horse’s breeder was ready to 
move him along, and our trainer thought there were a few different things to try 
with the runner. Besides, having never won a race, the 4-year-old gelding still 
had all his conditions.
The big bay was a pleasant horse and quiet in the stall but all business 
on race day. He was somewhat remarkable for a horse with all his conditions 
in front of him and 17 starts behind him; he understood his job and tried hard 
every time. This positive, hard-trying attitude made him a barn favorite … 
aside from being the “house” horse, owned by the trainer. 
The big bay didn’t run on Salix/Lasix (furosemide). In his early starts, he had 
the bleeding preventative, but his previous trainer had made the switch to drop 
Lasix, and his form seemed to improve. Our trainer didn’t think there was any 
reason to add it back, although the horse flattened out in more than one race. 
Nonetheless, in addition to historical improvement in form, there was a $1,000 
bonus for horses winning without medication, so why not go for the extra cash?
On a warm summer day with scattered clouds and a light breeze, our trainer 
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walked his horse over to the paddock for their seventh start together. The gelding 
had hit the board in most of those races, earning enough to pay his way, and the 
two had bonded. Our trainer knew that any horse that tried as hard as this one did 
would knock it out eventually, and the bettors shared his confidence, sending the 
gelding off as second choice. He thought today would be the day, as he legged up 
the jockey, his own brother, and sent the pair to the track.
The bay broke sharp, as our trainer knew he would, but ended up at the 
back of the pack by the first call. He settled into position on the outside of 
competitors and gradually moved up on several of them. As he hit the top of the 
stretch, he was off the lead by 5 ½ lengths but gaining on the outside. As he 
picked up tiring rivals, it became evident that he was tiring himself, and four 
strides after the wire, he collapsed.
Fear gripped our trainer’s heart. His own horse, the one he had carefully 
watched and clocked for months before deciding to buy and caring for him 
tirelessly, was laying on the track. It was not hot enough for a heat stroke, and 
the horse had been as clean and sound as any under his care. Our trainer ran to 
the wire, where his precious gelding was motionless. 
Nothing could be done. Perhaps it was a heart attack—certainly, most 
likely a heart attack, as the gelding’s legs were all intact as he lay there in a 
heap. At least he did not suffer, our trainer thought. He pulled off the bridle 
and blinked back tears as he made his way to the barn area. He had never lost 
a horse this way, and his mind was racing, going over everything that led up 
to this event to figure out if there was anything he could have done. If only he 
could have known.
The racing commission sent the horse off for a post-mortem examination 
to determine the cause of death.  Our trainer thought, “At least I will know what 
happened, which may give me an opportunity to prevent this from happening 
the future.”  After a few days, he inquired of the commission for the cause 
of death report and was informed that it was not available. Due to other 
circumstances surrounding that day (see sidebar on pg. 31), it took too long 
for our trainer to receive the report from the commission that revealed that his 
prized racehorse perished from exercise-induced pulmonary hemorrhage (EIPH). 
As the gelding ran his last strides, the capillaries in his lungs began to fail, 
with more blood leaking into his airways with every stride. The blood crossed 
into his airways, at first a trickle and then a gush, but the Thoroughbred would 
not give up because it was not in his nature to give up. However, as his lungs 
filled up, his ability to take in life-sustaining oxygen decreased to nothing, and 
he drowned in his own blood. 
Our trainer has since dispersed his horses and moved on to a new job. 
However, in an admonition to others, and armed with the knowledge of what 
happened that day, he is anxious to tell this story to other trainers, owners and 
regulators. Needless loss of life can be avoided. How? With Lasix.
What Is Exercise-Induced 
Pulmonary Hemorrhage (EIPH)?
What happened to this gelding afflicts a small fraction of horses racing 
throughout the world. Horses are highly efficient athletes, molded by eons of 
evolution to move huge volumes of blood across their exercising muscles as 
well as their lungs with each stride. They have been carefully designed for every 
stride to contribute to both active and stored energy—much like a rubber band 
stores energy—to minimize energy expenditure and maximize speed. Among the 
unique adaptations for optimal economy of motion are coupling the respiratory 
rate to galloping, a large powerful heart and high blood flow across the lungs 
(pulmonary circulation). In fact, blood traverses the pulmonary circulation so 
rapidly that it fails to fully oxygenate, a feature unique in the animal kingdom 
to horses. This exercise-driven high blood pressure in the pulmonary vessels 
pushes the pulmonary capillaries to the edge of failure. 
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In any racing horse, a fraction of these pulmonary blood vessels 
rupture, with the ruptures routinely appearing as blood in the windpipe 
post-race. About 80 percent of horses show blood in their tracheas post-
race, and about 1 percent of horses will bleed from the nose. This blood at 
the nose has been long recognized and termed “epistaxis,” originally made 
famous by the great-grandsire of Eclipse, an unraced but prolific son of the 
Darley Arabian, Bartlett’s Childers, aka “Bleeding Childers.”
A tiny percentage of the horses that bleed will die acutely on the 
racetrack, either while racing or within minutes of the end of the race. 
Death is caused by massive acute bleeding into the lungs, as happened to 
this gelding. The lungs fill with blood and the horse goes down, sometimes 
during the race, other times in the winner’s circle or maybe as the horse 
comes off the track. The cause of death—massive hemorrhage into the 
lungs and drowning in his own blood—can only be determined by a full 
post-mortem examination. This is a significant cause of death in racing 
horses; the best estimates are that somewhere between 60 percent and 
80 percent of non-musculoskeletal fatalities in racing are caused by acute 
EIPH, and when this happens during a race or when a horse is galloping out, 
it places the life of the rider and possibly other riders and horses at risk.
Bleeding Risk Factors
Lasix and EIPH may be the most extensively researched topic in the 
history of horse racing. However, because of different study designs, many 
of the studies appear contradictory. Nonetheless, several risk factors rise to 
the top as convincingly real from the studies available. First, EIPH causes 
damage in the lungs, and this damage is structural, which means that it is 
irreversible. The progressive nature of EIPH means that as horses that have 
bled accumulate more racing starts, the damage worsens over time. Since 
geldings tend to have more starts, they also appear to be at a higher risk.
Training and racing at altitude has repeatedly been associated with 
a higher risk of EIPH. Horsemen in the western United States have long 
considered EIPH to be altitude-related. The first formal identification of  
such a relationship came from Caracas, Venezuela, where the observed  
rate of EIPH was considerably greater than rates reported elsewhere at lower 
elevations. Following this identification, the EIPH rates at three different 
Venezuelan racetracks were compared and showed a direct altitude effect. 
Reviewing the scientific literature for a potential basis for this effect, it 
was noted that moving horses from sea level to altitude is immediately 
associated with quite a significant increase in pulmonary artery pressure, 
providing a physiological basis for the effect of altitude increasing the 
susceptibility to EIPH.
Effect of Lasix on Bleeding
So, what is the effect of Lasix on the incidence of epistaxis and 
EIPH? The best data we have is from New York racing, where Lasix was a 
prohibited substance until September 1995. This regulatory experiment in 
New York, when virtually all other jurisdictions permitted the use of Lasix 
under very strict controls, provides a clear answer to the benefits of the 
medication on the health and welfare of the horse. Prior to September 1995 
and the introduction of Lasix, the incidence of epistaxis, as determined 
by the chief examining veterinarian of the New York Racing Association, 
was about 58 cases per year. The epistaxis cases dropped dramatically 
to average 10 to 11 per year in the years after Lasix was approved. Given 
these facts, a reasonable conclusion is that running a horse “off Lasix” 
increases the risk of an EIPH-related event, such as occurred in this matter, 
approximately four-fold.
About 80 percent  
of horses show 
blood in their 
tracheas post- 
race, and about  
1 percent of horses 
will bleed from  
the nose.
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U.S. Jurisdictions  
with No-Lasix Races
The administration of Lasix on race day is legally permissible within all U.S. 
racing jurisdictions. Its administration is regulated by the local racing authority, 
and it is required to be administered no less than four hours prior to post for the 
race. In 18 of the 34 racing jurisdictions in the country, the administration must 
be performed by a third-party licensed veterinarian who is employed or approved 
by the local racing authority. The use of Lasix in every jurisdiction in the country 
is an example of how uniformity comes about when the regulations in question 
are in the best interest of both the sport and the athletes.
However, the narrative outlined above is a grim reminder of the reason that 
the use of Lasix has become widespread. Where monetary incentives are offered 
to trainers or owners to put their horses at risk, this outcome is unavoidable. 
To date, incentives for horses competing in medication-free races have been 
offered by tracks in Colorado, Arkansas and Florida. 
In addition, California’s racing authority, California Horse Racing Board 
(CHRB), has recently adopted a regulation to permit tracks to establish 
medication-based eligibility requirements that could prohibit the administration 
of any medication for a particular track even though such medication and its 
administration on race day is permitted by the CHRB. 
The Kentucky Horse Racing Commission (KHRC) also adopted a regulation 
entitled “International Medication Protocol” that permitted a track to prohibit 
the administration of furosemide less than 24 hours prior to post time as a 
condition of a race. The Kentucky attorney general found that this was an 
improper delegation of the discretionary function committed by statute to the 
KHRC and not a private racetrack.
Conclusion
The horseman profiled in this article has hung up his trainer’s license and 
moved on to other endeavors. While he misses the lifestyle, the last chapter was 
one of the worst series of events to ever befall a dedicated conditioner. He has 
continued his work with horses, just in the background, away from the excitement 
of the track. He was informed of the cause of death of his precious gelding too 
late to help any other horse under his care. The courage and heart of the big bay 
gelding, not overly talented but distinctive in his desire to try, had laid its imprint 
on the man’s life. 
The tragedy of the gelding’s death and the failure of the racing commission 
to pass on this information to the trainer in a timely manner—to at least aid in 
the prevention of this tragedy repeating itself—are inexcusable. For a modest 
monetary incentive, a horse is raced without Lasix, immediately placing him 
at a four-fold greater risk of an adverse EIPH-related event. On top of this 
basic EIPH risk rate, this horse was running at altitude, thereby increasing his 
adverse event risk rate on the order of 10-fold more than at sea level. Given 
these circumstances, the sequence of events occurring in this horse was not 
completely unexpected: The horse initially ran well, then slowed toward the end 
as his lungs filled with blood, and he died from asphyxiation very shortly after 
crossing the finish line. 
As is not uncommon in these acute death situations, there is no obvious 
blood at the nostrils, and the diagnosis of death from EIPH requires a necropsy 
examination. It was a tragic outcome for the horse and his trainer, but it could 
have been worse; incidents of acute sudden death from EIPH have the potential 
to result in injuries to riders and other horses, as has previously been noted. 
The trainer knows it is too late for his gelding but hopes that it is not too late 
for others. 
Lasix is not just the letter “L” in the program. It is permitted in every 
jurisdiction in the United States under carefully controlled conditions, and any 
attempt to eliminate or ban it, especially with the offer of bonus money or other 
advantages for racing without it, is an egregious assault on the health and 
welfare of Thoroughbreds and the brave men and women who ride them.
Lasix's administration is regulated by the local racing 
authority, and it is required to be administered no less 
than four hours prior to post for the race. In 18 of the 34 
racing jurisdictions in the country, the administration must 
be performed by a third-party licensed veterinarian who  
is employed or approved by the local racing authority.
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